Let's Talk Innovation

Let's Talk
Innovation

You are here

All Articles

03/03/2017
Lone Star State of Mind
Growing up in the northeast, I’ve always held certain preconceived notions about Texas. I’ve heard many of the quotes:
Full Article
01/16/2017
Belonging
New ways to detect, intercept, treat and track life threatening diseases were at the forefront of the 35th annual JP Morgan Healthcare Conference. But as much was made of the remarkable innovations highlighted at JPM, Johnson & Johnson Innovation’s Robert G. Urban, reflects on how much more can be accomplished when it comes to Diversity & Inclusion.
Full Article
01/06/2017
Diversity… more than a buzz word.
“It benefits everybody who experiences it (and) by disrupting conformity, it produces a public good,” say Sheen S. Levine, professor at the Jindal School of Management at the University of Texas at Dallas and David Stark, professor of sociology at Columbia.
Full Article
01/06/2017
JPM at 10
In 1991, we downloaded the world’s first Internet browser for the one-millionth time, sent the Hubble telescope into space and witnessed the early stages of analyzing DNA and sequencing genes through the Human Genome Project. A record-breaking 33 young biotech companies completed IPOs. And as Johnson & Johnson Innovation’s Robert G. Urban reminds us, we also gathered for the 10th annual J.P. Morgan Healthcare Conference to celebrate all that the biotechnology industry had accomplished in only a decade. All to remind us how hard it will be to imagine in just another 10 years.
Full Article
12/07/2016
Celebrating Transformational Innovators
Scientific researchers – in academia and the private sector – give us tremendous gifts of health and happiness. Anyone who has experienced the loss of a parent or a grandparent to Alzheimer's, or has taken medicine to treat a headache, or has avoided illness altogether thanks to a vaccine, knows the benefit of scientific progress is personal. Extending and improving lives eases more than human suffering – it also addresses the economic toll of life-threatening disease. Over the past four decades, life expectancy gains due to scientific advancement have added trillions of dollars per year to the economy in the US alone.
Full Article
12/07/2016
Expanding the Early-Stage Medical Device Ecosystem: JLABS @ M2D2 QuickFire Challenge Seeks Best Device Innovation
Today’s medical device advances are no longer just iterations of the surgical tools that have been used for decades. We are now seeing companies that can 3D-print patient-specific scaffolds to allow tissue integration for bone healing, and develop sealants to provide surgeons added assurance of reducing post-operative leaks. These and other medical innovations – previously unimagined – continue to improve the outlook for and health of patients.
Full Article
11/22/2016
Celebrating Transformational Innovation
While the thrill of scientific discovery is a great reward, many of the people behind some of the greatest innovations of our time go largely unrecognized. At Johnson & Johnson, we believe that scientific excellence and its impact on the world should be widely celebrated.
Full Article
11/02/2016
Why Storytelling Matters for Pharma: A Q&A with Ryan Flinn
Ryan Flinn’s official title at Johnson & Johnson is Innovation Integration Communications Leader, but it might as well be “storyteller.”
Full Article
11/01/2016
Meet Robert Radinsky, PhD, Vice President, Oncology Scientific Innovation, The Janssen Pharmaceutical Companies of Johnson & Johnson, Boston Innovation Center
What are some of the biggest challenges and opportunities in identifying and structuring collaborations within the oncology space?
Full Article
10/21/2016
Innovating the Biologics Supply Chain: New QuickFire Challenge Looks to Spark Ideas from Pharma and Beyond
The pharmaceutical supply chain is a complex yet well-orchestrated system responsible for bringing medicines from manufacturing all the way to patients.
Full Article

Pages